Wednesday, 4 August 2021

Synthetic biology company Zymergen plunges 68% after saying product revenue will be 'immaterial' in 2022, removing CEO

Three months after its IPO, Zymergen is warning investors that revenue is much further out than expected.

from Earnings https://ift.tt/3xhEwT3
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)